Abstract
Amiodarone is an extremely effective antiarrhythmic agent for the treatment of both life-threatening ventricular arrhythmias and refractory supraventricular tachyarrhythmias. Subjective minor side effects are common with amiodarone but rarely require discontinuation of therapy and are often handled by dose reduction. Serious end-organ toxicity, including pulmonry fibrosis and drug-induced hepatitis, have been the most common indications for discontinuing amiodarone therapy in these patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 246-253 |
| Number of pages | 8 |
| Journal | Medical Toxicology and Adverse Drug Experience |
| Volume | 4 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 1989 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Toxicology
Fingerprint
Dive into the research topics of 'Adverse Effects of Amiodarone: Pathogenesis, Incidence and Management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver